SCHEMBL24591619

SCHEMBL24591619

[N-]=[N+]=NC12O[C@@H](c3csc4c(N)ncnc34)C[C@@]1(O)C2O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21880479 0.81 POLRMT (0.35) —
SCHEMBL19644592 0.78 HIF1A (0.30) —
SCHEMBL19644580 0.78 HIF1A (0.30) —
SCHEMBL21880622 0.77 HIF1A (0.30) —
SCHEMBL21880480 0.76 — —
SCHEMBL24591606 0.76 — —
SCHEMBL19962233 0.76 HIF1A (0.32) —
SCHEMBL19962232 0.75 HIF1A (0.34) —
SCHEMBL21137110 0.71 HIF1A (0.33) —
SCHEMBL21880609 0.71 HIF1A (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
Send feedback